Finally, the effects of YY1 on cell proliferation and glutamine metabolism of ESCC cell lines (ECA109 and TE-1) were analyzed, and its potential molecular mechanism was discussed to provide a theoretical basis for ESCA to develop new clinical therapeutic strategies. The gene discussed is YY1; the disease is esophageal squamous cell carcinoma.